<DOC>
	<DOCNO>NCT00821262</DOCNO>
	<brief_summary>Patients undergo high risk cardiac surgery ( combine CABG valvular procedure ) randomize receive total intravenous anesthesia anesthesia plan sevoflurane . The investigator want document whether cardioprotective property volatile agent could translate improve outcome cardiac surgery high risk patient .</brief_summary>
	<brief_title>Sevoflurane Cardiac Surgery</brief_title>
	<detailed_description>Background It commonly believe choice primary anesthetic agent result different outcome cardiac surgery . Recent evidence however indicate volatile anesthetic improve post-ischemic recovery . These result summarize meta-analysis 22 randomized study , involve 1922 patient : use volatile anesthetic associate significant reduction myocardial infarction ( 24/979 [ 2.4 % ] volatile anesthetic group vs 45/874 [ 5.1 % ] control arm , odds ratio [ OR ] =0.51 [ 0.32-0.84 ] , mortality ( 4/977 [ 0.4 % ] v 14/872 [ 1.6 % ] , OR=0.31 [ 0.12-0.80 ] . Furthermore , use volatile anesthetic associate short intensive-care unit stay ( WMD=-7.10 hour [ -11.47 ; -2.73 ] , time hospital discharge ( WMD=-2.26 day [ -3.83 ; -0.68 ] . All study meta-analysis include low risk patient undergo isolated procedure ( mostly coronary artery bypass graft ) . Objectives Investigators plan large multicentre randomize control study confirm beneficial cardioprotective effect volatile anesthetic cardiac surgery indicate reduce intensive care stay and/or death high risk population patient undergo combined valvular coronary procedure . Secondary endpoint : cardiac troponin release ; incidence myocardial infarction ; time mechanical ventilation ; postoperative hospital stay Methods Various center randomize 200 patient receive either total intravenous anesthesia propofol anesthesia sevoflurane . All patient receive standard middle dose opiates anesthesia . All perioperative management otherwise identical standardize . Transfer intensive care perform SpO2 94 % great FiO2 0.5 less facemask , adequate cardiac stability hemodynamically significant arrhythmia , chest tube drainage le 50 ml/h , urine output great 0.5 ml/kg/h , intravenous inotropic vasopressor therapy excess dopamine 5 ug/kg/min , seizure activity . Expected Results The reduced cardiac damage ( reduction cardiac troponin release incidence myocardial infarction ) translate well tissue perfusion faster recovery document reduced intensive care unit .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>age &gt; 18 year write informed consent schedule procedure ongoing acute myocardial infarction cardiac troponin &gt; 1 ng/ml previous unusual response anesthetic use sulfonylurea , theophylline allopurinol thoracotomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Sevoflurane</keyword>
	<keyword>Anesthesia</keyword>
	<keyword>Troponin</keyword>
	<keyword>Myocardial Preconditioning</keyword>
	<keyword>Surgery , Cardiac</keyword>
	<keyword>Stents</keyword>
	<keyword>Non-cardiac Surgery</keyword>
	<keyword>Surgery</keyword>
</DOC>